Aprea AB is a biopharmaceutical company focused on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein, p53.

Company Name

Aprea

Company Website

http://www.aprea.com/

Location

Stockholm, Sweden

Investment Stage

IPO October 2019